Comparative effectiveness - Thinking beyond medication A versus medication B

New England Journal of Medicine

Volumn 361, Issue 4, 2009, Pages 331-333

  Volpp, Kevin G ^a,b   Das, Anup ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; VARENICLINE;

HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; LIFESTYLE; MEDICAL INFORMATION; MEDICAL RESEARCH; PRIORITY JOURNAL; SHORT SURVEY; SMOKING CESSATION;

EID: 67651148220     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp0903496     Document Type: Article

References (5)

1. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
2. Volpp KG, Troxel AB, Pauly MV, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med 2009;360:699-709.
3. Eisenberg MJ, Filion KB, Yavin D, et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ 2008;179:135-44.
4. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008;1:CD000146.
5. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007;1:CD000031